Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FD.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FD.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FD.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FD.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.245EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.245EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.245ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.245ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.245EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.245EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.245ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.245ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.403EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.403ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.403ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.403EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.403EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.403ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.403ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.636EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.636EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.636ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.636ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.636EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.636EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.636ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.636ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.126EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.126EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.126ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.126ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used